PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

First closing and launch of BioDiscovery 4

Edmond de Rothschild Investment Partners has held the first closing and launch of the fourth fund in its BioDiscovery franchise dedicated to investing in life sciences in France and in Europe.



Edmond de Rothschild Investment Partners reached its objective of EUR125m for the first closing in the expected timeframe and confirms its final objective of about EUR200m by the end of the year.

Edmond de Rothschild Investment Partners will deploy the same strategy for BioDiscovery 4 as for its previous funds.

The team will lead investments in 15 to 20 life science companies across all stages of development. The investments will be made both in therapeutic drug development companies and a combination of medical technology and molecular diagnostic companies.

The fund will invest mainly in Europe.

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured

Blackstone Private Equity